Confirmation of the tumor type was exhibited via a positive reaction to pan-cytokeratin, cytokeratin 5/6, and p63 (Fig 3) and negative immunohistochemistry for Epstein-Barr virus (EBV), SOX-10, and cytokeratin 20 (Table I). The gene discussed is KRT5; the disease is neoplasm.